Presentation Details

The Fourth International Conference on Knowledge, Culture and Change in Organisations

Drug supply chain management in US and China: A comparison study of the drug supply chain in mature market and the developing market

Zichao Li.

Drug distribution is the most intensively regulated business by the U.S. Food and Drug Administration (FDA) due to its importance among all commodity types. China, started opening its drug distribution business to private and foreign sector since end of 2003. What are the existing distribution models in the two countries? Will this new business in China evolve as what happened in US? What are the causes of differences? What are the existing management strategies used by foreign distributors in other industries to enter China market? This paper will cover the comparative study on all these aspects mentioned above and we'll also discuss some alternative ideas raised by other reseachers.


Zichao Li  (Singapore)
Graduate Student
School of Industrial and System Engineering
Georgia Institute of Technology

I am a graduate student from Georgia Institute of Technology. My area of interest is SCM research and inventory system research.

  • distribution management
  • supply chain management
  • managing uncertainty
  • drug supply chain
  • global purchasing group
  • distribution consortia

(Virtual Presentation, English)